Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162473 (
Frey
)
2,599
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Both central and peripheral axons contain pivotal microRNA (miRNA) proteins. While recent observations demonstrated that miRNA biosynthetic machinery responds to peripheral nerve lesion in an injury-regulated pattern, the physiological significance of this phenomenon remains to be elucidated. In the current paper we hypothesized that deletion of
Dicer
would disrupt production of
Dicer
-dependent miRNAs and would negatively impact regenerative axon growth. Taking advantage of tamoxifen-inducible CAG-CreERt:
Dicer
(fl/fl) knockout (
Dicer
KO), we investigated the results of
Dicer
deletion on sciatic nerve regeneration in vivo and regenerative axon growth in vitro. Here we show that the sciatic functional index, an indicator of functional recovery, was significantly lower in
Dicer
KO mice in comparison to wild-type animals. Restoration of mechanical sensitivity recorded in the von
Frey
test was also markedly impaired in
Dicer
mutants. Further,
Dicer
deletion impeded the recovery of nerve conduction velocity and amplitude of evoked compound action potentials in vitro. Histologically, both total number of regenerating nerve fibers and mean axonal area were notably smaller in the
Dicer
KO mice. In addition,
Dicer
-deficient neurons failed to regenerate axons in dissociated dorsal root ganglia (DRG) cultures. Taken together, our results demonstrate that knockout of
Dicer
clearly impedes regenerative axon growth as well as anatomical, physiological and functional recovery. Our data suggest that the intact
Dicer
-dependent miRNA pathway is critical for the successful peripheral nerve regeneration after injury.
...
PMID:Dicer-microRNA pathway is critical for peripheral nerve regeneration and functional recovery in vivo and regenerative axonogenesis in vitro. 2217 26